RPAM
KYNB

Rhenman & Partners Asset Management’s Kyntra Bio KYNB Stock Holding History

Rhenman & Partners Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,000
Closed -$2.82M – 90
2021
Q4 		$2.82M Hold
8,000
– – 0.19% 85
2021
Q3 		$2.04M Hold
8,000
– – 0.14% 86
2021
Q2 		$5.33M Hold
8,000
– – 0.36% 80
2021
Q1 		$6.94M Buy
8,000
+2,200
+38% +$2.34M 0.48% 60
2020
Q4 		$5.38M Hold
5,800
– – 0.44% 66
2020
Q3 		$5.96M Hold
5,800
– – 0.53% 58
2020
Q2 		$5.88M Sell
5,800
-4,200
-42% -$3.9M 0.63% 56
2020
Q1 		$8.69M Sell
10,000
-1,000
-9% -$994K 1.22% 36
2019
Q4 		$11.8M Sell
11,000
-800
-7% -$817K 1.29% 33
2019
Q3 		$10.9M Sell
11,800
-2,098
-15% -$2.3M 1.37% 30
2019
Q2 		$15.7M Buy
13,898
+6,318
+83% +$6.92M 1.73% 23
2019
Q1 		$10.3M Sell
7,580
-4,489
-37% -$6.09M 1.2% 34
2018
Q4 		$14M Buy
12,069
+2,021
+20% +$2.27M 1.6% 27
2018
Q3 		$15.3M Buy
10,048
+466
+5% +$718K 1.53% 29
2018
Q2 		$15M Buy
9,582
+2,800
+41% +$3.65M 1.53% 28
2018
Q1 		$7.83M Hold
6,782
– – 0.97% 44
2017
Q4 		$8.04M Buy
6,782
+962
+17% +$1.21M 1.09% 34
2017
Q3 		$7.83M Sell
5,820
-354
-6% -$373K 1% 39
2017
Q2 		$4.99M Hold
6,174
– – 0.72% 53
2017
Q1 		$3.81M Buy
6,174
+2,014
+48% +$1.23M 0.6% 60
2016
Q4 		$2.23M Hold
4,160
– – 0.43% 68
2016
Q3 		$2.15M Sell
4,160
-400
-9% -$188K 0.34% 77
2016
Q2 		$1.87M Hold
4,560
– – 0.33% 78
2016
Q1 		$2.43M Buy
4,560
+2,560
+128% +$1.28M 0.48% 70
2015
Q4 		$1.52M Buy
+2,000
New +$1.33M 0.23% 90

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Rhenman & Partners Asset Management's KYNB Position: Q1 2022 in Review

Rhenman & Partners Asset Management sold out of Kyntra Bio (KYNB) in Q1 2022, closing a stake of 8,000 shares — an estimated $2.82M sold.

Rhenman & Partners Asset Management first reported a position in KYNB in Q4 2015 and held it in 25 quarters. The position peaked at $15.7M in Q2 2019. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

  • Rhenman & Partners Asset Management reported no remaining Kyntra Bio position as of Q1 2022 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 8,000 Kyntra Bio shares in Q1 2022, an estimated $2.82M.
  • Rhenman & Partners Asset Management first reported a position in Kyntra Bio in Q4 2015 and held it in 25 quarters.
  • Rhenman & Partners Asset Management's Kyntra Bio position peaked at $15.7M in Q2 2019.
  • 156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2022, filed 13 May 2022.